Justin Daniel Salciccioli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
European Union | 12 | 2022 | 158 | 1.780 |
Why?
|
Out-of-Hospital Cardiac Arrest | 13 | 2024 | 340 | 1.600 |
Why?
|
Cardiopulmonary Resuscitation | 12 | 2024 | 997 | 1.490 |
Why?
|
Heart Arrest | 13 | 2024 | 1516 | 1.290 |
Why?
|
Anti-Asthmatic Agents | 2 | 2024 | 577 | 1.250 |
Why?
|
Thiamine | 3 | 2019 | 160 | 0.800 |
Why?
|
Neuromuscular Blockade | 2 | 2013 | 148 | 0.790 |
Why?
|
Asthma | 4 | 2024 | 6291 | 0.730 |
Why?
|
Pellagra | 1 | 2019 | 7 | 0.680 |
Why?
|
Niacin | 1 | 2019 | 117 | 0.620 |
Why?
|
Vitamin B Complex | 2 | 2019 | 299 | 0.590 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2023 | 843 | 0.530 |
Why?
|
Tongue | 1 | 2019 | 406 | 0.530 |
Why?
|
Europe | 11 | 2024 | 3436 | 0.510 |
Why?
|
Biological Products | 1 | 2024 | 948 | 0.490 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2023 | 944 | 0.480 |
Why?
|
World Health Organization | 7 | 2024 | 1329 | 0.460 |
Why?
|
Life Support Care | 1 | 2016 | 226 | 0.460 |
Why?
|
Cystic Fibrosis | 1 | 2023 | 1294 | 0.450 |
Why?
|
Databases, Factual | 10 | 2024 | 8080 | 0.440 |
Why?
|
Glucocorticoids | 1 | 2023 | 2167 | 0.430 |
Why?
|
School Health Services | 1 | 2017 | 388 | 0.420 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 744 | 0.420 |
Why?
|
Pseudomonas Infections | 1 | 2017 | 623 | 0.410 |
Why?
|
Diarrhea | 1 | 2019 | 1320 | 0.410 |
Why?
|
Lymphocyte Count | 1 | 2015 | 794 | 0.410 |
Why?
|
Incidence | 22 | 2024 | 21538 | 0.390 |
Why?
|
Immunocompromised Host | 1 | 2017 | 863 | 0.390 |
Why?
|
Hospital Mortality | 12 | 2022 | 5349 | 0.380 |
Why?
|
Atrial Flutter | 2 | 2023 | 253 | 0.340 |
Why?
|
Aortic Rupture | 2 | 2023 | 322 | 0.330 |
Why?
|
Pseudomonas aeruginosa | 1 | 2017 | 1276 | 0.330 |
Why?
|
Lactic Acid | 4 | 2019 | 1140 | 0.320 |
Why?
|
Quality-Adjusted Life Years | 7 | 2023 | 1741 | 0.320 |
Why?
|
Hydroxyl Radical | 1 | 2008 | 82 | 0.310 |
Why?
|
Peroxides | 1 | 2008 | 76 | 0.310 |
Why?
|
Stilbenes | 1 | 2008 | 155 | 0.290 |
Why?
|
Free Radical Scavengers | 1 | 2008 | 213 | 0.290 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3252 | 0.280 |
Why?
|
Lung Diseases | 1 | 2017 | 1944 | 0.280 |
Why?
|
Female | 69 | 2024 | 397192 | 0.270 |
Why?
|
Mortality | 11 | 2024 | 2911 | 0.270 |
Why?
|
Prealbumin | 1 | 2008 | 259 | 0.270 |
Why?
|
Male | 67 | 2024 | 364719 | 0.270 |
Why?
|
Humans | 92 | 2024 | 768166 | 0.270 |
Why?
|
Pneumonia | 1 | 2018 | 2163 | 0.260 |
Why?
|
Education, Medical | 2 | 2017 | 1742 | 0.250 |
Why?
|
Myocardial Ischemia | 3 | 2022 | 2138 | 0.240 |
Why?
|
Hypothermia, Induced | 4 | 2014 | 754 | 0.240 |
Why?
|
Critical Illness | 2 | 2015 | 2756 | 0.240 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1304 | 0.240 |
Why?
|
Heart Massage | 1 | 2024 | 32 | 0.240 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2171 | 0.240 |
Why?
|
Interleukin-5 | 1 | 2024 | 267 | 0.220 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2023 | 49 | 0.220 |
Why?
|
Hungary | 1 | 2023 | 82 | 0.220 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 164 | 0.200 |
Why?
|
Rib Fractures | 1 | 2024 | 124 | 0.200 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2023 | 1456 | 0.200 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15948 | 0.200 |
Why?
|
Budesonide | 1 | 2023 | 162 | 0.200 |
Why?
|
APACHE | 2 | 2012 | 268 | 0.200 |
Why?
|
Neutrophils | 1 | 2015 | 3786 | 0.200 |
Why?
|
Shock, Septic | 3 | 2014 | 774 | 0.190 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2023 | 1250 | 0.190 |
Why?
|
Cerebrovascular Disorders | 2 | 2021 | 1485 | 0.190 |
Why?
|
Intensive Care Units | 6 | 2021 | 3800 | 0.190 |
Why?
|
Thoracic Injuries | 1 | 2024 | 288 | 0.180 |
Why?
|
Stroke | 2 | 2022 | 9755 | 0.180 |
Why?
|
Femoral Neck Fractures | 1 | 2022 | 143 | 0.180 |
Why?
|
Acidosis, Lactic | 2 | 2013 | 145 | 0.180 |
Why?
|
Morbidity | 2 | 2023 | 1755 | 0.180 |
Why?
|
Vasoconstrictor Agents | 3 | 2019 | 656 | 0.180 |
Why?
|
Ubiquinone | 2 | 2012 | 181 | 0.170 |
Why?
|
Administration, Inhalation | 1 | 2023 | 1169 | 0.170 |
Why?
|
Intestinal Obstruction | 1 | 2023 | 433 | 0.170 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1695 | 0.170 |
Why?
|
Body Temperature | 2 | 2014 | 780 | 0.160 |
Why?
|
Steroids | 1 | 2024 | 938 | 0.160 |
Why?
|
Weather | 1 | 2020 | 234 | 0.160 |
Why?
|
Bronchodilator Agents | 1 | 2023 | 518 | 0.160 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7454 | 0.160 |
Why?
|
Cytochromes c | 1 | 2019 | 173 | 0.160 |
Why?
|
Leukocyte Count | 2 | 2015 | 1609 | 0.160 |
Why?
|
Stockings, Compression | 1 | 2018 | 36 | 0.160 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5176 | 0.150 |
Why?
|
Endovascular Procedures | 2 | 2023 | 2216 | 0.150 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1240 | 0.150 |
Why?
|
Endocarditis, Bacterial | 1 | 2022 | 436 | 0.150 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 677 | 0.150 |
Why?
|
Endocarditis | 1 | 2022 | 352 | 0.150 |
Why?
|
Brain Edema | 2 | 2014 | 601 | 0.150 |
Why?
|
Piperacillin | 1 | 2017 | 37 | 0.150 |
Why?
|
United States | 16 | 2024 | 73039 | 0.140 |
Why?
|
Penicillanic Acid | 1 | 2017 | 41 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2023 | 565 | 0.140 |
Why?
|
Gout | 1 | 2024 | 621 | 0.140 |
Why?
|
Defibrillators | 1 | 2017 | 39 | 0.140 |
Why?
|
Middle Aged | 35 | 2024 | 223492 | 0.140 |
Why?
|
London | 1 | 2017 | 233 | 0.130 |
Why?
|
Anaphylaxis | 1 | 2024 | 758 | 0.130 |
Why?
|
Appendicitis | 1 | 2023 | 690 | 0.130 |
Why?
|
Disabled Persons | 2 | 2023 | 1210 | 0.130 |
Why?
|
Treatment Outcome | 16 | 2024 | 65371 | 0.130 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2017 | 111 | 0.130 |
Why?
|
Graft Survival | 2 | 2023 | 3887 | 0.130 |
Why?
|
Patient Preference | 1 | 2023 | 946 | 0.130 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 707 | 0.130 |
Why?
|
Medical Audit | 1 | 2017 | 454 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 789 | 0.120 |
Why?
|
Aged | 30 | 2024 | 171504 | 0.120 |
Why?
|
Developed Countries | 3 | 2024 | 451 | 0.120 |
Why?
|
Emergency Medical Services | 3 | 2016 | 1947 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
Predictive Value of Tests | 8 | 2015 | 15454 | 0.120 |
Why?
|
Hip Fractures | 1 | 2022 | 997 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1162 | 0.110 |
Why?
|
Tissue and Organ Procurement | 1 | 2022 | 986 | 0.110 |
Why?
|
Sex Distribution | 3 | 2024 | 2278 | 0.110 |
Why?
|
England | 3 | 2023 | 533 | 0.110 |
Why?
|
Hypertension, Pulmonary | 1 | 2024 | 1605 | 0.110 |
Why?
|
Cost of Illness | 4 | 2024 | 1951 | 0.110 |
Why?
|
Rewarming | 1 | 2013 | 64 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6316 | 0.100 |
Why?
|
Ventricular Function | 1 | 2014 | 405 | 0.100 |
Why?
|
Adrenergic beta-Agonists | 1 | 2014 | 347 | 0.100 |
Why?
|
Aged, 80 and over | 16 | 2024 | 59629 | 0.100 |
Why?
|
Lactates | 1 | 2013 | 401 | 0.100 |
Why?
|
Abdomen | 1 | 2018 | 1136 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1216 | 0.100 |
Why?
|
Adult | 19 | 2024 | 223646 | 0.100 |
Why?
|
Retrospective Studies | 21 | 2024 | 81762 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5863 | 0.100 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2018 | 521 | 0.100 |
Why?
|
Austria | 2 | 2022 | 208 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 2062 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2023 | 2401 | 0.090 |
Why?
|
Sodium | 1 | 2017 | 1597 | 0.090 |
Why?
|
Czech Republic | 2 | 2022 | 75 | 0.090 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 320 | 0.090 |
Why?
|
Prevalence | 4 | 2024 | 15869 | 0.090 |
Why?
|
Nervous System Diseases | 2 | 2012 | 1662 | 0.090 |
Why?
|
Myoclonus | 1 | 2011 | 107 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1667 | 0.090 |
Why?
|
Respiratory Rate | 1 | 2012 | 180 | 0.090 |
Why?
|
Epinephrine | 1 | 2014 | 794 | 0.090 |
Why?
|
Prospective Studies | 11 | 2019 | 54926 | 0.090 |
Why?
|
Sepsis | 1 | 2024 | 2608 | 0.090 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2655 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 937 | 0.090 |
Why?
|
ROC Curve | 3 | 2012 | 3628 | 0.090 |
Why?
|
Norway | 2 | 2022 | 501 | 0.080 |
Why?
|
Cohort Studies | 8 | 2024 | 41754 | 0.080 |
Why?
|
Regression Analysis | 4 | 2021 | 6340 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13586 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2016 | 2357 | 0.080 |
Why?
|
Logistic Models | 5 | 2017 | 13290 | 0.080 |
Why?
|
Vertigo | 1 | 2011 | 205 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2014 | 969 | 0.080 |
Why?
|
Sweden | 2 | 2023 | 1382 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2043 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3447 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1514 | 0.080 |
Why?
|
Data Collection | 2 | 2022 | 3327 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2080 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2360 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2018 | 1279 | 0.080 |
Why?
|
Hydrogen Bonding | 1 | 2008 | 289 | 0.080 |
Why?
|
Career Choice | 1 | 2014 | 769 | 0.080 |
Why?
|
Oxygen Consumption | 1 | 2014 | 1880 | 0.070 |
Why?
|
Diabetic Ketoacidosis | 1 | 2011 | 257 | 0.070 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 804 | 0.070 |
Why?
|
Schools | 1 | 2017 | 1498 | 0.070 |
Why?
|
Crystallization | 1 | 2008 | 520 | 0.070 |
Why?
|
Risk Factors | 7 | 2023 | 74944 | 0.070 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1157 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9263 | 0.070 |
Why?
|
Registries | 4 | 2021 | 8375 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13671 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2022 | 4262 | 0.070 |
Why?
|
Positive-Pressure Respiration | 1 | 2012 | 713 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7477 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4058 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8509 | 0.070 |
Why?
|
Bacteremia | 2 | 2012 | 986 | 0.070 |
Why?
|
Age Distribution | 2 | 2024 | 2873 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4282 | 0.060 |
Why?
|
Lung | 1 | 2024 | 10099 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3109 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1614 | 0.060 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 1085 | 0.060 |
Why?
|
Time Factors | 5 | 2020 | 40218 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1932 | 0.060 |
Why?
|
Patient Discharge | 4 | 2024 | 3479 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2018 | 1883 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2017 | 20760 | 0.060 |
Why?
|
Liver | 1 | 2020 | 7577 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 810 | 0.060 |
Why?
|
Molecular Structure | 1 | 2008 | 1883 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3886 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3573 | 0.060 |
Why?
|
Crystallography, X-Ray | 1 | 2008 | 1951 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5367 | 0.050 |
Why?
|
General Surgery | 1 | 2014 | 1720 | 0.050 |
Why?
|
Emergency Service, Hospital | 5 | 2014 | 7951 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4270 | 0.050 |
Why?
|
Vitamins | 1 | 2011 | 1638 | 0.050 |
Why?
|
Young Adult | 5 | 2023 | 60066 | 0.050 |
Why?
|
Belgium | 1 | 2022 | 119 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1024 | 0.050 |
Why?
|
Ribs | 1 | 2024 | 259 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2022 | 11101 | 0.050 |
Why?
|
Luxembourg | 1 | 2021 | 1 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13014 | 0.050 |
Why?
|
Histocompatibility Testing | 1 | 2023 | 716 | 0.050 |
Why?
|
Bulgaria | 1 | 2021 | 17 | 0.050 |
Why?
|
Health Status Disparities | 2 | 2024 | 1885 | 0.050 |
Why?
|
Ireland | 1 | 2021 | 170 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5706 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1964 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2725 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10840 | 0.050 |
Why?
|
Recovery of Function | 1 | 2011 | 2981 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 2010 | 2191 | 0.040 |
Why?
|
Stroke Volume | 1 | 2014 | 5622 | 0.040 |
Why?
|
Gross Domestic Product | 1 | 2020 | 77 | 0.040 |
Why?
|
Survival Analysis | 4 | 2014 | 10101 | 0.040 |
Why?
|
Graft Rejection | 2 | 2023 | 4492 | 0.040 |
Why?
|
Hospitals, Urban | 2 | 2012 | 497 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4887 | 0.040 |
Why?
|
Sunlight | 1 | 2020 | 337 | 0.040 |
Why?
|
Germany | 1 | 2021 | 883 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1334 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3007 | 0.040 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2018 | 24 | 0.040 |
Why?
|
Adolescent | 4 | 2024 | 89169 | 0.040 |
Why?
|
Length of Stay | 1 | 2011 | 6498 | 0.040 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3239 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24315 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12252 | 0.030 |
Why?
|
Odds Ratio | 3 | 2017 | 9669 | 0.030 |
Why?
|
Cytokines | 1 | 2012 | 7453 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7852 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2021 | 21206 | 0.030 |
Why?
|
Prognosis | 5 | 2019 | 30010 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1265 | 0.030 |
Why?
|
Northern Ireland | 1 | 2016 | 37 | 0.030 |
Why?
|
Wales | 1 | 2016 | 87 | 0.030 |
Why?
|
Sex Factors | 2 | 2024 | 10632 | 0.030 |
Why?
|
Scotland | 1 | 2016 | 142 | 0.030 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3415 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1969 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1103 | 0.030 |
Why?
|
State Medicine | 1 | 2017 | 219 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1886 | 0.030 |
Why?
|
Databases as Topic | 1 | 2016 | 472 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2234 | 0.030 |
Why?
|
Tissue Donors | 1 | 2023 | 2381 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 403 | 0.030 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2024 | 1483 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2463 | 0.030 |
Why?
|
Age Factors | 3 | 2015 | 18412 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2021 | 1506 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1377 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1826 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26379 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10873 | 0.020 |
Why?
|
Electric Countershock | 1 | 2014 | 534 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2389 | 0.020 |
Why?
|
Acute Disease | 2 | 2012 | 7243 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 472 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4860 | 0.020 |
Why?
|
Pilot Projects | 2 | 2014 | 8741 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 570 | 0.020 |
Why?
|
Tidal Volume | 1 | 2012 | 518 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14729 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 693 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12077 | 0.020 |
Why?
|
Calibration | 1 | 2011 | 819 | 0.020 |
Why?
|
Child | 1 | 2017 | 80917 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39348 | 0.020 |
Why?
|
Observation | 1 | 2010 | 310 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10399 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15832 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1643 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22371 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8542 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2923 | 0.020 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2010 | 359 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2661 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5458 | 0.020 |
Why?
|
Cross Infection | 1 | 2014 | 1426 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2258 | 0.010 |
Why?
|
Reference Values | 1 | 2012 | 4938 | 0.010 |
Why?
|
Critical Care | 1 | 2017 | 2715 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8748 | 0.010 |
Why?
|
Liver Diseases | 1 | 2012 | 1305 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10760 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2403 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8890 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12840 | 0.010 |
Why?
|
Survivors | 1 | 2011 | 2381 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2012 | 4310 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10590 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3251 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6974 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36743 | 0.000 |
Why?
|